Completed NA INTERVENTIONAL 2-arm NCT04063644

Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients

Effect of Visglyc on the Quality of Life of Patients With Dry Eye Symptomatology and Age-related Loss of Visual Acuity

Sponsor: OPKO Health, Inc.

Interventions Physiological saline solution Vis Glyc Neo

Updated 6 times since 2019 Last updated: Mar 19, 2021 Started: May 30, 2019 Primary completion: Dec 22, 2020 Completion: Dec 22, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cataract and Dry Eye Syndromes and is currently completed. OPKO Health, Inc. leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting NA
Oct 2019 — Jan 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Sep 2019 — Oct 2019 [monthly]

Recruiting NA

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OPKO Health, Inc.

Data source: OPKO Health, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain